Earn CPD by completing on-demand modules. Claim CPD in the Educational Activities (EA), Reviewing Performance (RP) and Measuring Outcomes (MO) categories, depending on the specifics outlined within each module.
Pancreatic disease can have extensive consequences on a patient’s health and well-being. Pancreatic disease can often be silent, subtle and deceptive. Moreover, our understandings of how to tackle these diseases and their major consequences continues to evolve. This expert-led education module focuses on three of the commonest pancreatic disorders: cancer, chronic pancreatitis and pancreatic exocrine insufficiency. These presentations provide authoritative and practical explanations to help you develop your understanding of the diagnosis and management of these conditions.
This mini-audit will focus on understanding whether or not older patients in your practice are having cardiac auscultation done at a frequency sufficient to detect valvular disease in its early stages, and to detect more advanced valvular disease that may not yet be suspected.
This presentation brings together a ‘brains-trust’ in the management of menstrual problems and menstrual pain. Using a case study, the panel will attempt to provide a practical and evidence-based approach to the management of the symptoms presented and will also bring their own considerable personal experience and opinions to the discussion.
The 2023 influenza season is expected to start early and be more severe than the last few years. It’s important for front line immunisers to be updated with the latest information, public health advice and practical strategies for this year’s season. Influenza causes a large burden of disease in Australia with sick days, hospitalisation and death. Vaccination is readily available and updated yearly to include the most recent strains. It is widely recommended across the community, but especially for the most vulnerable including the very young, old, Indigenous Australians, and people with underlying comorbidities.
This course is aimed at helping clinicians maximise the effectiveness of MHT while minimising the potential risks across a range of circumstances and scenarios. The most effective treatment for troublesome symptoms of menopause is still hormone therapy. Body identical hormones are now available which offer a number of clinical advantages. Moreover, drug delivery options are also varied – patch, pill, gel, etc. so clinicians can work with patients to determine which hormones and which delivery system is best suited to their needs.
This activity will focus on dementia prevention in primary care and will involve sending a link to a standardised questionnaire (CogDrisk) aimed at calculating a risk profile and identifying modifiable risk factors for dementia to all your patients between age 45-65, discussing the results with your patients and reporting on the outcomes in the report template provided.
For many years it has been mooted that not all menopausal symptoms are caused by lack of oestrogen alone. Testosterone therapy in women has been proven to improve sexual desire in carefully selected patients. It is a valid treatment in those who are distressed by their lack of sexual desire where there is no other cause obvious for this. How, what, where and in whom are the challenges faced by treating clinicians. In this learning module, some of Australia's leading experts will discuss the evidence, describe their clinical experience and provide practical advice on how best to apply this emerging therapeutic option.
Featuring leading women’s health expert, Dr Terri Foran and a discussion panel of leading experts – Prof Deborah Bateson, Prof Rod Baber and Dr Lina Safro – this masterclass covers a wide range of information on the OCP.